Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma

Pediatric Acute Lymphoblastic Leukemia (ALL) cure rates have improved exponentially over the past five decades with now over 90% of children achieving long-term survival. A direct contributor to this remarkable feat is the development and expanded understanding of combination chemotherapy. Asparagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Maese, Luke, Rau, Rachel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279693/
https://www.ncbi.nlm.nih.gov/pubmed/35844739
http://dx.doi.org/10.3389/fped.2022.902117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279693/
https://www.ncbi.nlm.nih.gov/pubmed/35844739
http://dx.doi.org/10.3389/fped.2022.902117

Ejemplares similares